Piramal Group

Mumbai, India Founded: 1984 • Age: 42 yrs
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
Request Access

About Piramal Group

Piramal Group is a company based in Mumbai (India) founded in 1984.. The company has 16,400 employees as of March 31, 2024. Piramal Group has completed 8 acquisitions, including Ash Stevens, Biosyntech and Coldstream Labs. Piramal Group offers products and services including Housing Finance, Pharma Solutions, and Realty Development. Piramal Group operates in a competitive market with competitors including Abzena, Patheon, Syngene, Panacea Biotec and Maravai Life Sciences, among others.

  • Headquarter Mumbai, India
  • Employees 16400 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Piramal Enterprises Ltd.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $788.08 M (USD)
    18.19
    as on Mar 31, 2024
  • Net Profit
    $56.66 M (USD)
    128.8
    as on Mar 31, 2024
  • EBITDA
    $375.12 M (USD)
    28.71
    as on Mar 31, 2024
  • Latest Funding Round
  • Investors
  • Employee Count
    16400

    as on Mar 31, 2024

  • Investments & Acquisitions
    Ash Stevens

    & 7 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Piramal Group

Piramal Group is a publicly listed company on the NSE with ticker symbol PPLPHARMA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NSE · Ticker: PPLPHARMA . Sector: Health technology · India

Products & Services of Piramal Group

Piramal Group offers a comprehensive portfolio of products and services, including Housing Finance, Pharma Solutions, and Realty Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Provides loans and financing for housing needs

Offers manufacturing and distribution of pharmaceutical products

Focuses on property development and community projects

People of Piramal Group
Headcount 5000-10000
Employee Profiles 80
Board Members and Advisors 13
Employee Profiles
People
Sai Kumar
Trainee-regulatory Affairs
People
Ajay Piramal
Chairman & Executive Director
People
Anand Piramal
Executive Director, Piramal Group
People
Rupen Jhaveri
Group President, Piramal Enterprises Limited

Unlock access to complete

Board Members and Advisors
people
Vijay Shah
Non-Executive Director
people
Nitin Nohria
Advisor
people
Anjali Bansal
Independent Director
people
Kunal Bahl
Independent Director

Unlock access to complete

Funding Insights of Piramal Group

  • Total Funding
  • Total Rounds 4
  • Last Round
  • First Round
  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2020 Amount Post-IPO - Piramal Group Valuation

investors

Dec, 2019 Amount Post-IPO - Piramal Group Valuation

investors

Oct, 2019 Amount Post-IPO - Piramal Group Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Piramal Group

Piramal Group has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include The Carlyle Group, Caisse de depot et placement du Quebec and Department of Biotechnology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investment strategies are provided across diverse asset classes and markets.
Founded Year Domain Location
Private equity investments are directed toward multiple sectors.
Founded Year Domain Location
Biotechnology research, guidelines, and funding by the Government of India.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Piramal Group

Piramal Group has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Ash Stevens, Biosyntech and Coldstream Labs. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Formulation development and contract manufacturing services are provided in pharmaceuticals.
2007
Care coordination solutions for healthcare organizations
2007
A single-use device used to obtain biopsies of bone
2005
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Piramal Group

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Piramal Group Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Piramal Group

Piramal Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abzena, Patheon, Syngene, Panacea Biotec and Maravai Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of antibody discovery, cell line development, and bio analytics services
domain founded_year HQ Location
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
domain founded_year HQ Location
Provider of contract research and manufacturing services for both small molecules and biologics
domain founded_year HQ Location
Developer of biosimilars, vaccines and natural products
domain founded_year HQ Location
Provides enabling tools and services in the life sciences research and bio-production industries
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Piramal Group

Frequently Asked Questions about Piramal Group

When was Piramal Group founded?

Piramal Group was founded in 1984 and raised its 1st funding round 27 years after it was founded.

Where is Piramal Group located?

Piramal Group is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.

Who is the current CEO of Piramal Group?

Peter De Young is the current CEO of Piramal Group.

How many employees does Piramal Group have?

As of Mar 31, 2024, the latest employee count at Piramal Group is 16,400.

What is the annual revenue of Piramal Group?

Annual revenue of Piramal Group is $788.08M as on Mar 31, 2024.

What does Piramal Group do?

Founded in 1984 and headquartered in Mumbai, India, Piramal Group maintains a multinational presence across pharmaceuticals, healthcare services, life sciences, specialty glass packaging, and real estate sectors. Subsidiaries such as Piramal Healthcare, Piramal Capital, Decision Resources Group, Piramal Glass, Piramal Realty, and Piramal Foundation are included. Contract development and manufacturing solutions for first-in-class drugs, generics, and antibody drug conjugates are provided to pharma and biotech firms.

Who are the top competitors of Piramal Group?

Piramal Group's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.

What products or services does Piramal Group offer?

Piramal Group offers Housing Finance, Pharma Solutions, and Realty Development.

Is Piramal Group publicly traded?

Yes, Piramal Group is publicly traded on NSE under the ticker symbol PPLPHARMA.

How many acquisitions has Piramal Group made?

Piramal Group has made 8 acquisitions, including Ash Stevens, Biosyntech, and Coldstream Labs.

Who are Piramal Group's investors?

Piramal Group has 3 investors. Key investors include The Carlyle Group, Caisse de depot et placement du Quebec, and Department of Biotechnology.

What is Piramal Group's ticker symbol?

The ticker symbol of Piramal Group is PPLPHARMA on NSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available